Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AST-120 in mild hepatic encephalopathy
NCT00867698Phase 2Completed
- Sponsor
- Ocera Therapeutics
- Start
- Mar 2009
- Primary completion
- Apr 2010
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 2 trial of activated charcoal in hepatic encephalopathy (HE), sponsored by Ocera Therapeutics. Started Mar 2009; status: completed.
02
Drugs
activated charcoal
03
Conditions
hepatic encephalopathy (HE)
Beyond the preview
Go deeper on NCT00867698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00867698.